Business Wire

Mevion Receives 510(k) Clearance for HYPERSCAN Pencil Beam Scanning

Del

Mevion Medical Systems has received FDA 510(k) clearance for the MEVION S250i Proton Therapy System ® including HYPERSCAN™ pencil beam scanning (PBS) technology. HYPERSCAN PBS introduces novel energy layer switching and automated collimation systems. These advantages enable the S250i™ system to deliver faster, sharper, and more robust PBS proton radiation treatments.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180103005398/en/

The MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning is shown here, fully inst ...

The MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning is shown here, fully installed at MedStar Georgetown University Hospital. Georgetown University Hospital will be the first hospital in the world to deliver proton therapy using HYPERSCAN technology. (Photo: Business Wire)

“The S250i system represents the next generation of intensity modulated proton therapy (IMPT) delivered in the most compact proton therapy platform,” said Joseph Jachinowski, CEO of Mevion Medical Systems. “We are proud that the MEVION S250i system now has received both FDA clearance and CE mark. This is a very important milestone in our efforts to make precision proton therapy available to more patients in the fight against cancer.”

Next Generation Intensity Modulated Proton Therapy (IMPT)
The MEVION S250i™ system is a compact proton therapy system capable of delivering conformal radiation therapy treatments using HYPERSCAN pencil beam scanning technology. The design of HYPERSCAN PBS technology overcomes clinical challenges that were previously faced by first generation PBS systems.

Pencil beam scanning systems shape the delivered radiation dose by “painting” tumors spot-by-spot and layer-by-layer with sub-atomic particles. Prior to HYPERSCAN PBS, scanning proton systems struggled with delivery speed. Long delivery times can undermine the high precision of the treatment due to the target tumor shifting under normal organ motion such as breathing.

HYPERSCAN PBS uses a compact beam delivery path reducing delivery times to less than 5 seconds for some fields. This “hyper-fast” treatment delivery reduces treatment errors due to the sensitivity to motion that current PBS technologies face when treating tumors affected by organ motion.

In addition, HYPERSCAN PBS utilizes, the Adaptive Aperture™ proton multi-leaf collimator (pMLC). This technology uses a robotically controlled collimation system, capable of trimming the edges of the beam at every layer of delivery. This capability delivers up to a three times sharper drop off in radiation at the delivery field edge. This improves sparing of healthy tissue and limits unnecessary radiation to sensitive locations.

World’s First HYPERSCAN PBS Installation
MedStar Georgetown University Hospital in Washington, D.C. will be the first hospital in the world to offer this latest generation of HYPERSCAN PBS once final onsite testing is completed this month.

“We are excited to be not only the first and only proton therapy system in the Washington, D.C. area, but also the first in the world to offer these advanced proton therapy treatment capabilities to our patients and community. Currently, patients who seek proton therapy need to leave the metropolitan D.C. area, which can be a significant burden on families,” said Brian T. Collins, MD, clinical director of MedStar Georgetown Proton Therapy Center. “We will now be delivering advanced proton therapy, fully integrated into our broad set of comprehensive cancer care offerings. This is critical to the patients we serve.”

Built on Leading Compact Proton Therapy Technology
The MEVION S250i system is based on Mevion’s high efficiency, low financial risk S250™ Series platform. The core technology of the S250 Series is the world’s only gantry mounted superconducting synchrocyclotron. This compact, fully integrated platform has years of successful clinical experience and proven financial viability.

While proton therapy has clear dosimetric advantages, the costs of early systems has been a significant barrier to adoption. The MEVION S250i reduces this barrier through lower capital costs, reduced operating costs, and increased treatment throughput. Mevion customers have achieved the fastest per-room patient ramp-up in the history of proton therapy. Demonstrating that compact proton therapy is a viable option for any size cancer center is core to Mevion’s mission of making proton therapy accessible to as many patients as possible.

About Mevion Medical Systems®
Mevion Medical Systems, Inc. is a leading provider of proton therapy systems for use in radiation treatment for cancer patients. Mevion is based in Littleton, Massachusetts, with a presence in the Europe, Japan and China. For more information, please visit www.mevion.com.

Follow Mevion on Twitter: https://twitter.com/mevionmedical

Connect with Mevion on LinkedIn: https://www.linkedin.com/company/mevion-medical-systems

LPR180103

Contact information

Mevion
Melanie Benton, 978-540-1551
mbenton@mevion.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Javier Gómez Noya Chooses ROKA Eyewear26.4.2018 18:15Pressemelding

ROKA, the Austin-based performance design company, has announced a multiyear eyewear partnership with eight-time triathlon world champion and Olympic silver medalist Javier Gómez Noya, expanding their existing relationship for technical race apparel and equipment. Starting in 2018, Gómez will train and race in ROKA’s eyewear, the lightest, most advanced performance optics in the world, in the pursuit of his first Ironman World Championship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180426006510/en/ Javier Gómez Noya Chooses ROKA Eyewear (Photo: Business Wire) “I first tried the Advanced Performance eyewear while I was at ROKA’s headquarters in Texas, and right away I knew they were the glasses I should be using everyday,” Gómez Noya says. “There’s nothing like them in terms of weight, retention, and quality of vision. Whether cycling or running, you can’t feel that you’re wearing them but you have an incredible field of

Egyptian Singer Becomes First Woman to Perform Before a Mixed Crowd in Saudi Arabia26.4.2018 17:55Pressemelding

History was made in Saudi Arabia on Wednesday as a female singer performed before a mixed audience for the first time in the country. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180426006471/en/ Egypt’s National Arab Music Ensemble of the Egyptian Opera House debuted in Saudi Arabia with the singer Nihad Fathy performing before a 2,500-strong audience in Riyadh. This is the first time a woman singer performed on stage in the Kingdom before a mixed crowd. (Photo courtesy of GCA Saudi Arabia.) Egypt’s National Arab Music Ensemble (AME) of the Egyptian Opera House debuted in the Kingdom with the singer Nihad Fathy performing before a 2,500-strong audience at King Fahad Cultural Center in Riyadh. The crowd broke into a rapturous applause as she took to the stage. The Egyptian Opera House ensemble, which was led by famous conductor Moustafa Helmy, comprised 45 male and female musicians and singers, including the star singers A

Pharnext Appoints Amit Kohli as Chief Operating Officer26.4.2018 16:00Pressemelding

Regulatory News: Pharnext SA (Paris:ALPHA) (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based on big genomic data and artificial intelligence, today announced the appointment of Amit Kohli, a senior healthcare industry executive, as Chief Operating Officer (COO). Mr. Kohli is responsible for leading Pharnext’s corporate strategy and operations. “Amit is a seasoned leader with over 20 years’ experience in the healthcare industry, and we are thrilled he is joining Pharnext,” said Prof. Daniel Cohen, M.D., Ph.D., Co-Founder and Chief Executive Officer of Pharnext. “We are deeply impressed with Amit’s results-oriented track record, and his ability to drive business strategy and operations across the pharma, medtech and clinical diagnostics sectors. We believe Pharnext will greatly benefit from his extensive cross-functional leadership experience especially as our first-in-class orphan drug, PXT3003, for the

Leading Marine Container Leasing Management Team Launches Global Container International26.4.2018 15:33Pressemelding

Jeffrey Gannon and Adrian Dunner, in partnership with investment vehicles managed by Wafra Inc., today announced the formation of Global Container International LLC (“Global”), a new marine container leasing platform headquartered in Boston, Massachusetts and with representation in Hong Kong, Shanghai, Singapore, Antwerp, Taipei, and Seoul. With a near-term goal of building a fleet of 1 million TEU (twenty-foot equivalent units), Global is positioned to provide its customers a reliable alternative source of capital and containers for lease. Jeffrey Gannon serves as Chief Executive Officer of Global, and Adrian Dunner serves as Chief Operating Officer. Together, they offer clients a combined 50 years of experience backed by successful track records in the container leasing industry. Global will invest in marine containers and related equipment made available for lease under a wide range of structures to meet customer needs. Investments will include new build containers, portfolio purcha

TimeXtender Discovery Hub® is Now Microsoft Azure Certified26.4.2018 14:00Pressemelding

TimeXtender, a recognized global software company enabling instant access to any type of data in the organization to support advanced analytics and artificial intelligence (AI), today announced that its Discovery Hub® solution has been tested, approved and certified for readiness and compatibility to run in Microsoft Azure environments. With this certification, Discovery Hub® is now a trusted application that is available in the Microsoft Azure Marketplace. The Azure Marketplace is an extensive catalog of products from independent software vendors (ISVs). Azure Marketplace allows IT professionals and developers to confidently search for Microsoft Azure certified products and solutions. “To be published in the Azure Marketplace, a solution goes through a number of certification steps to validate the platform, solution and software,” said Heine Krog Iversen, CEO at TimeXtender. “Given these requirements, we’re pleased that Discovery Hub® has been certified to run on Microsoft Azure. This

Andersen Global Announces Collaboration in Peru26.4.2018 13:30Pressemelding

Andersen Global continues its expansion in Latin America through a Collaboration Agreement with Picon & Asociados, a tax and legal practice that encompasses a full range of private and corporate services. Picon & Asociados, located in Lima, enhances Andersen’s provision of best-in-class service globally. Jorge Picon leads the team in Peru. “Picon & Asociados is an excellent fit for our global organization and the collaboration addresses another key market in South America,” remarked Mark Vorsatz, Global Chairman and Andersen Tax LLC CEO. “The practice, which includes nearly 40 professionals, provides us with added legal capabilities and enhances our core tax business in the region.” Jorge added, “Creating value for our clients by providing high quality, specialized tax and legal services is a top priority, and working with professionals that share this mindset is very important to us. Our team is committed to providing best-in-class solutions for our clients and we look forward to coll